Geron Corporation · Menlo Park, CA United States ·(NASDAQ (GM): GERN)
Company Description
View Geron Corporation Locations On A US Map
This link will open in a new window
This link will open in a new window Not far from the center of the controversy over human embryonic stem cell (hESC) research is Geron. The company hopes to parlay its work into viable therapies for various diseases and conditions. One of the company's lead products is a hESC therapy called GRNOPC1 for spinal cord injury which was approved to enter the world's first hESC human clinical trials until the FDA put a hold on the trials while the agency reviewed new data. Geron is also focused on anticancer drug candidate GRN163L, which inhibits telomerase, an enzyme that may prolong cellular life and prevents apoptosis (programmed cell death). Geron has been in business since 1992 and has subsidiaries in Scotland and Hong Kong. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Geron Corporation Financials
| Company Type | Public - NASDAQ (GM): GERN Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $2.8 |
| 2008 Employees | 159 |
Geron Corporation Executives
16 executives listed for Geron Corporation's Menlo Park, CA location.
| Title | Name & Bio | Contact |
| Chairman | Alexander Barkas | Network |
| President, CEO, and Director; President, Oncology | Thomas Okarma | Network |
| EVP, CFO, Treasurer, and Secretary | David Greenwood | Network |
Competition
Competitive Landscape for Geron Corporation
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Geron Corporation Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!